Cannabis explained
Endometriosis affects an estimated 190 million people worldwide, and gaps in care are leading to an increased interest in cannabis-based medicines. What do we know about how these might help, and does the science support it?
News
Jodie Yettram ·
News
Jodie Yettram ·
News
Jodie Yettram ·
Journalism built on science, not speculation.
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall
Pain specialist Dr Michael Überall discusses cannabinoid-based medicines, opioids, and what meaningful improvement looks like for patients.
Dr Sue Clenton explores the growing interest and potential of cannabinoid-based therapies to address unmet needs in women’s health.
Pharmacist Nitin Makadia will discuss safer prescribing and lessons from European medical cannabis care at Frankfurt’s symposium on 4 November.
Science & Evidence — Spotlight
We read the studies so you don’t have to — separating robust findings from headlines, with the methods and caveats laid bare.
Explore the research
Plain-language guides to conditions, cannabinoids and what the evidence actually says.
Explore patient guidesRegulatory change, clinical evidence and the patient perspective for prescribers and pharmacists.
Enter the clinical hubWhy clinicians attend the symposiumDirectory
Browse verified UK medical cannabis clinics and pharmacies — online and in person.
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall
